Maya Ilouze

Fluorescence In Situ Hybridization, Immunohistochemistry, and Next-Generation Sequencing for Detection of EML4-ALK Rearrangement in Lung Cancer

Marina Pekar‐Zlotin, Fred R. Hirsch, Lior Soussan‐Gutman et al. · The Oncologist · 2015 · 147 citations · Full text

Medicine, Molecular Biology, Oncology +17

Next-Generation Sequencing Identifies and Immunohistochemistry Confirms a Novel Crizotinib-Sensitive ALK Rearrangement in a Patient with Metastatic Non–Small-Cell Lung Cancer

Nir Peled, Gary A. Palmer, Fred R. Hirsch et al. · Journal of Thoracic Oncology · 2012 · 132 citations · Full text

Medicine, Oncology, Pharmacology +17

Exhaled Breath Analysis for Monitoring Response to Treatment in Advanced Lung Cancer

Inbar Nardi Agmon, Manal Abud-Hawa, Ori Liran et al. · Journal of Thoracic Oncology · 2016 · 131 citations · Full text

Medicine, Oncology, Pharmacokinetics +15

Volatile fingerprints of cancer specific genetic mutations

Nir Peled, Orna Barash, Ulrike Tisch et al. · Nanomedicine Nanotechnology Biology and Medicine · 2013 · 121 citations

Medicine, Genetics, Oncology +14

Detection of Lung Cancer and EGFR Mutation by Electronic Nose System

Dekel Shlomi, Manal Abud, Ori Liran et al. · Journal of Thoracic Oncology · 2017 · 96 citations · Full text

Medicine, Molecular Biology, Oncology +10